Members of the Washington University in St. Louis community are invited to host Washington University students in their homes for casual dinner and conversation through the Home Plate program.
An experienced attorney, relative to a first-timer, increases the likelihood of winning a case by 14 percentage points and of capturing a justice’s vote by 11 percentage points.
A global study comparing 2,062 birds finds that, in highly variable environments, birds tend to have either larger or smaller brains relative to their body size. New research from Carlos Botero, assistant professor of biology in Arts & Sciences, finds birds with smaller brains tend to use ecological strategies that are not available to big-brained counterparts.
Chancellor Andrew D. Martin has announced the organizational realignment of the Division of Student Affairs to report to his office, effective immediately. Vice Chancellor for Student Affairs Lori S. White, who had previously served under the provost, will now report directly to Martin.
Effective fall 2019, the start and end times for day classes on the Danforth Campus will be observed “as listed” (i.e., as published in Course Listings) with the transition time between classes taking place at the end of the published time, instead of at the beginning of the published time.
Nadine Strossen, author of the Common Reading Program selection “Hate: Why We Should Resist It with Free Speech, Not Censorship,” will deliver the keynote address at “Reflections: Unity, Social Justice, and Peace,” an annual event celebrating the start of the academic year at Washington University. The event begins at 4 p.m. Monday, Aug. 26, in Graham Chapel.
Investigators at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have been awarded a $15 million grant to better understand the genetic changes that drive acute myeloid leukemia (AML), a deadly blood cancer, and predict patients’ responses to therapy. The findings also may enable investigators to develop more effective therapies tailored to patients, based on the genetic characteristics of their cancer cells.
